PE

Advertisement
Dec 12 2025TECHNOLOGY

How AI Chatbots Are Becoming Our Go-To Companions

People are using AI chatbots for more than just quick answers. These tools have become personal coaches, tutors, and even friends. But what makes AI act as a coworker or a confidant? A recent study looked into this question by analyzing millions of conversations with Copilot, a popular AI chatbot.

reading time less than a minute
Dec 12 2025POLITICS

A Clash of Views: Trump, Pope, and the Future of Europe

In a recent interview, former U. S. President Donald Trump made some strong statements about Europe and NATO. He said that European countries are struggling with immigration and are too weak to handle their problems. He also criticized how Europe has managed the Russia-Ukraine war and suggested that

reading time less than a minute
Dec 12 2025POLITICS

Europe's Growing Tensions: A Call to Arms

Europe is facing a serious situation. The head of NATO has warned that Europe must get ready for a big conflict, similar to what their grandparents went through. This warning comes after Russia has been acting more aggressively. There have been drone attacks in NATO airspace and Russia's president h

reading time less than a minute
Dec 12 2025POLITICS

Why Is the U. S. Still in NATO?

Some people in the U. S. government think it's time for the country to leave NATO. They say the organization is old and no longer useful. Rep. Thomas Massie from Kentucky introduced a bill to do just that. He believes the U. S. should focus on its own defense instead of paying for other countries.

reading time less than a minute
Dec 12 2025HEALTH

Spit Science: New Clues to Gum Disease

Researchers are digging into spit to find clues about gum disease. They want to spot trouble early. Gum disease can be mild or severe. It's a big deal for oral health. The study looked at proteins in saliva. These proteins are part of the TAM pathway. The goal was to see if these proteins could tel

reading time less than a minute
Dec 12 2025HEALTH

What People Really Think About COVID Drugs: A Twitter Tale

During the COVID-19 pandemic, people talked a lot about drugs on Twitter. Some of these drugs were approved by the FDA, while others were not. A study looked at over 600, 000 tweets to see what people thought about these drugs. The study found that Hydroxychloroquine and Ivermectin were talked abou

reading time less than a minute
Dec 12 2025ENTERTAINMENT

Kyland and Taylor: Racing Hearts and Friendship on The Amazing Race

Kyland Young and Taylor Hale, known from Big Brother, teamed up on The Amazing Race 38. Their journey was filled with ups and downs, both in the race and in their relationship. They started strong, winning an Express Pass and giving it to Jas and Jag Bains. This choice sparked debates among fans, bu

reading time less than a minute
Dec 12 2025POLITICS

Europe's Shifting Stance on Migrant Rights

Europe is rethinking its approach to migrant rights. This shift comes as political parties across the continent toughen their stance on immigration. The Council of Europe, a group of 46 nations, recently agreed to explore changes that could weaken protections for migrants. These protections have bee

reading time less than a minute
Dec 12 2025SPORTS

A Comeback Victory for The Citadel

The Citadel basketball team faced a tough challenge against Southern Wesleyan. They started slow, missing their first six shots and falling behind 7-0. But they didn't give up. Dante Kearse, a bench player, stepped up big time. He scored 15 points, including five 3-pointers. His performance sparked

reading time less than a minute
Dec 12 2025FINANCE

Hedge Funds Navigate Market Shifts in November

November was a month of ups and downs for hedge funds. Despite a rough start with tech stocks taking a hit, big names like Citadel, Balyasny, and Point72 still managed to make gains. Citadel, based in Miami and led by billionaire Ken Griffin, saw its main fund, Wellington, rise by 1. 4%. This bring

reading time less than a minute